← Evidence map

ArticleTheranostics2023

Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity.

Hyun Young Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37056568